State Of Wyoming Lexicon Pharmaceuticals, Inc. Transaction History
State Of Wyoming
- $826 Million
- Q3 2025
A detailed history of State Of Wyoming transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wyoming holds 8,526 shares of LXRX stock, worth $11,765. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,526Holding current value
$11,765% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
130Shares Held
225MCall Options Held
431KPut Options Held
138K-
Artal Group S.A. Luxembourg, N4136MShares$188 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$53.7 Million1.9% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$13.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.85MShares$12.2 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY4.58MShares$6.32 Million0.03% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $260M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...